{
    "clinical_study": {
        "@rank": "55249", 
        "acronym": "PIO laser SPNP", 
        "arm_group": {
            "arm_group_label": "Selective laser trabeculoplasty (Tango Laser, Ellex)", 
            "arm_group_type": "Experimental", 
            "description": "Patients treated with selective laser trabeculoplasty (Tango Laser, Ellex, Minneapolis, USA)"
        }, 
        "brief_summary": {
            "textblock": "The main objective of this study is to characterize the changes in IOP over 24 hours after\n      selective trabeculoplasty SLT (before and 1 and 6 months after treatment, decreased IOP,\n      type of rhythm, mesor, acrophase, amplitude). The secondary objective is to evaluate changes\n      in ocular perfusion pressure (arterial pressure - IOP) and ocular blood flow in the optic\n      nerve head after selective laser trabeculoplasty."
        }, 
        "brief_title": "PIO Laser Sclerectomy IOP SLT Sclerectomy", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Primary Open-Angle Glaucoma", 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Primary Open-Angle Glaucoma\n\n          -  IOP more than 21 mmHg\n\n          -  Progression under maximal medical therapy\n\n          -  aged more than 18 years\n\n        Exclusion Criteria:\n\n          -  Pregnant woman"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01798732", 
            "org_study_id": "1012", 
            "secondary_id": "2010-A00932-37"
        }, 
        "intervention": {
            "arm_group_label": "Selective laser trabeculoplasty (Tango Laser, Ellex)", 
            "description": "One session of selective laser trabeculoplasty with the following parameters (inferior half-circumference, 50 shots, 0.8 to 1.3 mJ)", 
            "intervention_name": "Selective Laser Trabeculoplasty (Tango Laser, Ellex)", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 28, 2014", 
        "location": {
            "contact": {
                "last_name": "Jean-Paul Romanet, MD", 
                "phone": "+ 33 476 765 548"
            }, 
            "facility": {
                "address": {
                    "city": "Grenoble", 
                    "country": "France"
                }, 
                "name": "University Hospital of Grenoble"
            }, 
            "investigator": {
                "last_name": "Jean-Paul Romanet, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of Selective Laser Trabeculoplasty on the Intraocular Pressure Nycthemeral Rhythm.", 
        "overall_official": {
            "affiliation": "University Hospital, Grenoble", 
            "last_name": "Jean-Paul ROMANET, Pr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "IOP change over 24 hours after selective trabeculoplasty SLT according to chronobiological data (decrease of IOP; type of 24h-IOP rhythm and 24h-PPm rhythm: MESOR, acrophase, bathyphase, amplitude and modeling)", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 6 months"
        }, 
        "reference": {
            "PMID": "22025580", 
            "citation": "Khayi H, Pepin JL, Geiser MH, Tonini M, Tamisier R, Renard E, Baguet JP, Levy P, Romanet JP, Chiquet C. Choroidal blood flow regulation after posture change or isometric exercise in men with obstructive sleep apnea syndrome. Invest Ophthalmol Vis Sci. 2011 Dec 16;52(13):9489-96. doi: 10.1167/iovs.11-7936."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01798732"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To find predictive factors 1 month before efficacy of the treatment (after 6 month). Efficacy is defined by a mean IOP decrease, at least 30%, with a smoothed pressure-peaks (decrease at least 40% of pressure changes)\nTo characterize changes of ocular blood flow parameters (optic nerve head; Volume, Velocity and Flow): 20% at least of increase.", 
            "measure": "Changes in the rate of ocular perfusion pressure (arterial pressure - IOP) and ocular blood flow in the optic nerve head after SLT.", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 6 months"
        }, 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}